Bris­tol My­ers set­tles an­ti-gener­ic HIV drug scheme al­le­ga­tions for al­most $11M

Al­though Bris­tol My­ers Squibb isn’t ad­mit­ting to any wrong­do­ing, the bio­phar­ma com­pa­ny agreed to pay al­most $11 mil­lion to set­tle al­le­ga­tions filed in a Cal­i­for­nia …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER